Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance P.

Biohealthmatics.com - Search our database for Health Informatics Journals, Healthcare IT Journals, Bioinformatics Journals and Biotechnology Journals.

Sign Up

Biohealthmatics Centers

Home

Jobs Search

Career Center

Networking Center

Company Profiles

Knowledge Center

Industry News

Web Directory

Industry Books

Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance P.

Rameshwar P, Gascon P, Bandari PS, Joshi DD, Fernandes A, Dang A.

Department of Medicine, UMDNJ-New Jersey Medical School, Newark 07103, USA. rameshwa@umdnj.edu

Publication Date: Tuesday, June 11, 2002

Click here to view MEDLINE citation

More June, 2002 proteomics journal articles.

Molecular diagnostics: hurdles for clinical implementation.

The promise of biomarkers in cancer screening and detection.

Proteomics of Arabidopsis seed germination. A comparative study of wild-type and gibberellin-deficient seeds.

Early detection of pancreatic carcinoma.

The human genome project and its impact on psychiatry.

Acid-labile formylation of amino terminal proline of human immunodeficiency virus type 1 p24(gag) was found by proteomics using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.

The immunopathogenesis of multiple sclerosis.

Proteomics analysis of carbon-starved Mycobacterium smegmatis: induction of Dps-like protein.

Protein microarrays to detect protein-protein interactions using red and green fluorescent proteins.

Sequence mapping of epoxide adducts in human hemoglobin with LC-tandem MS and the SALSA algorithm.

What do we want from proteomics in the detection and avoidance of adverse drug reactions.

Proteomics of the eukaryotic transcription machinery: identification of proteins associated with components of yeast TFIID by multidimensional mass spectrometry.

Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics.

Sub-proteome differential display: single gel comparison by 2D electrophoresis and mass spectrometry.

Regulatory control of genetically modified (GM) foods: likely developments.

Identification of novel candidates for replicative senescence by functional proteomics.

Identification of end points relevant to detection of potentially adverse drug reactions.

Muscular dystrophy into the new millennium.

Bacterial proteomics and vaccine development.